The biotech industry continued its work to develop lifesaving innovations—and these innovations, like vaccines, are what allow us to return to in-person events.
“We’ll be even stronger because of our diversity, and the synergy that it brings,” says Paul Hastings, President and CEO of Nkarta and Chair of BIO.
He’ll be at the BIO International Convention in San Diego in June—will you?